[1]
M. Ivanova, N. Skalii, and D. Ivanov, “Use of Angiotensin Receptor Blockers in Combination Therapy of Patients with Essential Hypertension and Diabetes Mellitus”, KIDNEYS, no. 2.12, pp. 41–44, Jan. 2022.